Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A single T cell receptor recognizes structurally distinct MHC/peptide complexes with high specificity

M D Tallquist1, T J Yun, L R Pease

  • 1Department of Immunology, Mayo Foundation, Rochester, Minnesota 55905, USA.

The Journal of Experimental Medicine
|September 1, 1996
PubMed
Summary

Researchers identified a novel allopeptide, dEV-8, recognized by the 2C T cell receptor (TCR) on Kbm3 molecules but not Ld molecules. This finding sheds light on how a single TCR can recognize distinct peptide/MHC complexes, impacting allorecognition understanding.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The impact of congenital heart disease on somatic growth: a monozygotic twin study.

European journal of pediatrics·2025
Same author

Cluster Analysis of DSC MRI, Dynamic Contrast-Enhanced MRI, and DWI Parameters Associated with Prognosis in Patients with Glioblastoma after Removal of the Contrast-Enhancing Component: A Preliminary Study.

AJNR. American journal of neuroradiology·2022
Same author

<i>MGMT</i> Promoter Methylation Status in Initial and Recurrent Glioblastoma: Correlation Study with DWI and DSC PWI Features.

AJNR. American journal of neuroradiology·2021
Same author

Dynamic Contrast-Enhanced MR Imaging of Nonenhancing T2 High-Signal-Intensity Lesions in Baseline and Posttreatment Glioblastoma: Temporal Change and Prognostic Value.

AJNR. American journal of neuroradiology·2019
Same author

Application of 3D Fast Spin-Echo T1 Black-Blood Imaging in the Diagnosis and Prognostic Prediction of Patients with Leptomeningeal Carcinomatosis.

AJNR. American journal of neuroradiology·2018
Same author

Can Arterial Spin-Labeling with Multiple Postlabeling Delays Predict Cerebrovascular Reserve?

AJNR. American journal of neuroradiology·2017

Area of Science:

  • Immunology
  • Molecular Biology
  • T cell receptor (TCR) research

Background:

  • The 2C T cell is a CD8+ alloreactive T cell that recognizes cells expressing Ld and Kbm3 class I major histocompatibility complex (MHC) molecules.
  • Understanding the specificity of T cell recognition is crucial for immunology and transplantation.

Purpose of the Study:

  • To characterize a novel allopeptide, dEV-8, recognized by the 2C TCR.
  • To investigate the degenerate recognition capabilities of the 2C TCR.
  • To identify the endogenous source of the dEV-8 allopeptide.

Main Methods:

  • Biochemical and immunological characterization of the allopeptide dEV-8.
  • Amino acid sequencing to deduce the peptide sequence.
  • Isolation and identification of the endogenous protein source.

Related Experiment Videos

Main Results:

  • The allopeptide dEV-8 was identified as a ligand for the 2C TCR in the context of the Kbm3 MHC molecule, but not the Ld molecule.
  • Biochemical and immunological properties showed dEV-8 is distinct from P2Ca, another Ld-restricted allopeptide recognized by the 2C TCR.
  • The endogenous protein MLRQ was identified as containing a peptide sequence identical to dEV-8.

Conclusions:

  • The 2C TCR exhibits degenerate recognition, binding to two distinct peptide/MHC complexes (Kbm3/dEV-8 and Ld/P2Ca).
  • This degenerate recognition has significant implications for understanding the mechanisms of allorecognition.
  • Identification of MLRQ provides insight into the natural presentation of peptides recognized by alloreactive T cells.